Clinical Trial Update: A Trial Assessing the Effect of Pembrolizumab Combined with Radiotherapy in Patients with Relapsed, Refractory, Specified Stages of Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides (MF)/Sezary Syndrome (SS) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating pembrolizumab in combination with radiotherapy for relapsed, refractory cutaneous T-cell lymphoma, specifically mycosis fung…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Mycosis Fungoides
• Sezary Syndrome

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: University College, London | Conditions: Cutaneous T Cell Lymphoma, Mycosis Fungoides/Sezary Syndrome | Phase 2 | Status: ACTIVE_NOT_RECRUITING